Lecznicze działanie rdzenia roślinnego – na stawy i żylaki. Jak przygotować maść z rdzenia?

Common comfrey (*Symphytum officinale*), also referred to by its colloquial names knitbone, boneset, or bruisewort, represents a hardy perennial herbaceous plant belonging to the borage family (*Boraginaceae*), indigenous to temperate regions of Europe, including Poland. This botanical species thrives predominantly in moisture-rich environments—frequently encountered along riverbanks, within floodplain forests, at the peripheries of wooded areas, and in drainage ditches where soil retention favors its growth. The flowering phase occurs between late spring and early summer, specifically from May through June, during which the plant produces distinctive campanulate inflorescences. These blossoms typically exhibit a color spectrum ranging from soft pink to deep violet or magenta, with occasional creamy-white variants observed in certain cultivars. The foliage is characterized by elongated, lanceolate leaves with acuminate tips, while mature specimens may attain heights exceeding one meter. The root system, which constitutes the primary medicinal component, extends both vertically (up to 30 cm in depth) and laterally, forming a branched, dark brown to blackish rhizome with a rough, often tuberous exterior. Phytochemical analysis of comfrey roots reveals a diverse array of bioactive compounds, including steroidal saponins, mucilaginous polysaccharides with demulcent properties, trace amounts of volatile oils, the storage carbohydrate inulin, allantoin—a compound renowned for its tissue-regenerative effects—tannins with astringent qualities, and rosmarinic acid, a phenolic acid demonstrating significant anti-inflammatory and antimicrobial activity. Historically, comfrey root preparations were administered internally in folk medicine as infusions intended to alleviate gastrointestinal disturbances such as indigestion and diarrhea. However, contemporary pharmacological research has identified the presence of pyrrolizidine alkaloids (PAs) within the plant—highly hepatotoxic secondary metabolites capable of inducing cumulative liver damage, including hepatic veno-occlusive disease and cirrhosis. Consequently, regulatory agencies now restrict comfrey’s therapeutic use exclusively to topical applications, such as ointments, poultices, or liniments, while oral ingestion is categorically contraindicated. This prohibition is particularly stringent for vulnerable populations, including pregnant women, lactating mothers, and pediatric patients, owing to their heightened susceptibility to PA-induced hepatotoxicity.

The primary bioactive compound in common comfrey (*Symphytum officinale*) is allantoin, a heterocyclic urea derivative that plays a pivotal role in therapeutic processes. Owing to its distinctive osmotic properties, this compound significantly accelerates wound epithelialization and facilitates the repair of damaged tissues. Additionally, allantoin exhibits astringent effects, which contribute to the reduction of inflammatory states, while simultaneously stimulating epidermal regeneration, thereby expediting the healing of ulcerations. Its soothing properties are also evident in the alleviation of skin irritations, the mitigation of psoriatic symptoms, and the prevention of ultraviolet radiation-induced damage, effectively guarding against sunburn. Notably, comfrey is further employed in the alleviation of rheumatic pain, including sciatica. The plant also contains tannins, which enhance its astringent action, as well as rosmarinic acid—a potent antioxidant with well-documented anti-inflammatory properties—further amplifying its medicinal potential.

Ointments derived from comfrey (*Symphytum officinale*) have long been recognized as a therapeutic agent for musculoskeletal disorders, including chronic arthritis, gout, rheumatoid joint pain, and degenerative conditions such as osteoarthritis. Its multifaceted pharmacological profile—encompassing anti-inflammatory, analgesic, and tissue-regenerative properties—renders it equally effective in managing traumatic injuries like sprains, dislocations, and contusions. Clinical trials have demonstrated that topical application of comfrey-based preparations can alleviate pain with efficacy comparable to diclofenac, a widely used nonsteroidal anti-inflammatory drug (NSAID). Notably, in patients suffering from advanced knee osteoarthritis, a three-week treatment regimen resulted in a 55% reduction in reported pain levels during both physical activity and rest, underscoring its potential as a non-pharmacological alternative for chronic joint discomfort.

For centuries, the root of *Symphytum officinale* (common comfrey) has occupied a pivotal position in traditional herbal medicine as a remedy for symptoms associated with chronic venous insufficiency, including acute vascular wall inflammation, persistent diffuse pain, and soft-tissue edema. In contemporary phytotherapy, standardized extracts derived from this botanical source—following rigorous pharmacological processing—are now incorporated into modern topical formulations such as ointments, gels, and dietary supplements designed to enhance peripheral circulation and promote venous tissue regeneration.

This topical formulation incorporates an extract derived from the root of comfrey (*Symphytum officinale*), blended with a lipid-based carrier system. The plant serves as a primary natural reservoir of allantoin—a bioactive compound clinically demonstrated to enhance cellular proliferation and facilitate the repair of damaged tissue matrices, thereby accelerating the healing of wounds from diverse etiologies. The formulation is further augmented by choline, which exerts anti-edematous effects through modulation of capillary permeability, and rosmarinic acid, whose anti-inflammatory mechanism involves the inhibition of pro-inflammatory cytokine synthesis and mediator release. The preparation is particularly indicated for inflammatory and degenerative joint disorders, including rheumatoid arthritis, musculoskeletal pain syndromes, and arthritic conditions such as osteoarthritis. Clinical evidence confirms that consistent application in patients with rheumatoid arthritis results in a reduction of morning joint stiffness exceeding 90%. Additionally, owing to its broad-spectrum efficacy, the ointment may be employed as an adjunctive therapy for mechanical injuries (fractures, dislocations, sprains—particularly of the knee and ankle joints) as well as chronic soft-tissue inflammation. Its antiseptic and antibacterial properties also render it suitable for managing recalcitrant wounds, thermal burns, frostbite, pressure ulcers, and even certain dermatological conditions such as plaque psoriasis, rosacea, and atopic dermatitis, where it demonstrates soothing effects and promotes re-epithelialization.

Preparing a homemade comfrey (*Symphytum officinale*) ointment represents a straightforward yet highly effective method of harnessing the medicinal properties of this botanical remedy. While commercially produced versions are readily available in pharmacies and herbal shops, crafting the ointment independently ensures complete transparency regarding ingredients and quality. The traditional formulation requires: **500 milliliters of freshly ground or powdered comfrey root**, **200 milliliters of 40% ethanol** (to extract bioactive compounds), **500 milliliters of glycerin** (as a humectant), and a **lipid base**—options include **cosmetic petroleum jelly, shea butter, lard, or goose fat**. For those seeking a simplified approach, the alcohol and glycerin may be omitted, significantly reducing preparation time. It is critical to note that comfrey contains **toxic pyrrolizidine alkaloids**, rendering it unsafe for internal consumption; however, topical applications in the form of ointments, poultices, or infused oils remain entirely safe. Consistent use of the preparation may alleviate joint discomfort, muscle soreness, and minor traumatic injuries.